The precise measurement of states in atomic and molecular systems can help to validate fundamental physics theories and their ...

A molecule named NM102 selectively inhibits the Mfd protein, a bacterial virulence and mutation factor, thereby disarming pathogenic bacteria without affecting beneficial microbiota.

A hit shows that there is “at least in principle, a molecule out there in the universe that does what I want it to,” he says. “At least it de-risks the concept.” In addition to considering ...

Could the secret to glowing, youthful skin be hiding in your brain? Dr. Nicholas Perricone, a leading dermatologist and nutritionist, has spent decades warning that chronic inflammation is one ...

A different, more optimized version of the molecule, called PX578, has been advanced to the clinic. That compound recently entered Phase 1 trials.

With just 48 hours to experiment before it would become unusable, a group of nearly 20 researchers focused intently on creating a brand-new molecule. Using a chemical glove box, a polycarbonate ...

Ozempic, Wegovy sales have soared in recent years Shortages and insurance coverage have made it difficult to get The naturally occurring molecule shows promise in suppressing appetite BRINP2 ...

Scientists discover new heavy-metal molecule 'berkelocene'. ScienceDaily . Retrieved May 24, 2025 from www.sciencedaily.com / releases / 2025 / 03 / 250311121130.htm ...

Takeda has returned to BridGene Biosciences for another small-molecule collaboration—this time focused on immunology as well as neurology. BridGene’s pursuit of undruggable targets is enabled ...

Researchers have now also found a chemical solution: a molecule that arranges itself into complex, non-repeating patterns on a surface. The resulting aperiodic layer could even exhibit novel ...

Earlier this year, they released that data as training fodder in a competition aimed at determining whether any AI models for predicting small molecule interactions with proteins were really ...

Experts from the University of of Dundee's Centre for Targeted Protein Degradation (CeTPD), working with Boehringer Ingelheim scientists, have developed a breakthrough small-molecule drug ...